A compromise on patent waivers for Covid-19 vaccines takes a key step at the WTO

May 3, 2022 |
Pfizer faces criticism for arguing that intellectual property for its Covid-19 pill is a human right
As Poor Nations Seek Covid Pills, Officials Fear Repeat of AIDS Crisis
Related Posts
Access to Medicines

Pharma Pricing Secrecy Run...
Funding the Fight

Congress’s Spending Bill...
Health Justice

PEPFAR can’t kee...